Sensitization of renal carcinoma cells to TRAIL-induced apoptosis by rocaglamide and analogs
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sensitization of renal carcinoma cells to TRAIL-induced apoptosis by rocaglamide and analogs
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-27
DOI
10.1038/s41598-018-35908-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rocaglates as dual-targeting agents for experimental cerebral malaria
- (2018) David Langlais et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bax/Bak-independent mitochondrial depolarization and reactive oxygen species induction by sorafenib overcome resistance to apoptosis in renal cell carcinoma
- (2017) Bernhard Gillissen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma
- (2017) Salomon Manier et al. Science Translational Medicine
- Synthesis of rocaglamide derivatives and evaluation of their Wnt signal inhibitory activities
- (2016) Midori A. Arai et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4A
- (2016) Jennifer Chu et al. Cell Reports
- A Microplate-Based Nonradioactive Protein Synthesis Assay: Application to TRAIL Sensitization by Protein Synthesis Inhibitors
- (2016) Curtis J. Henrich PLoS One
- Cytotoxic chemotherapy in the treatment of advanced renal cell carcinoma in the era of targeted therapy
- (2015) E. Diamond et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Translation Inhibition by Rocaglates Is Independent of eIF4E Phosphorylation Status
- (2015) J. Chu et al. MOLECULAR CANCER THERAPEUTICS
- Withanolide E sensitizes renal carcinoma cells to TRAIL-induced apoptosis by increasing cFLIP degradation
- (2015) C J Henrich et al. Cell Death & Disease
- A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf Pathway
- (2015) Shufeng Liu et al. EBioMedicine
- Molecular mechanisms and anti-cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines)
- (2014) Min Li-Weber INTERNATIONAL JOURNAL OF CANCER
- Biomimetic Kinetic Resolution: Highly Enantio- and Diastereoselective Transfer Hydrogenation of Aglain Ketones To Access Flavagline Natural Products
- (2014) Steven D. Stone et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation
- (2014) ZHOU LUAN et al. Molecular Medicine Reports
- Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species
- (2014) Li Pan et al. NATURAL PRODUCT REPORTS
- Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1
- (2013) J Lemke et al. CELL DEATH AND DIFFERENTIATION
- Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family
- (2013) K Azijli et al. CELL DEATH AND DIFFERENTIATION
- Flavaglines: potent anticancer drugs that target prohibitins and the helicase eIF4A
- (2013) Christine Basmadjian et al. Future Medicinal Chemistry
- The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints
- (2013) Jennifer Neumann et al. INTERNATIONAL JOURNAL OF CANCER
- Tight Coordination of Protein Translation and HSF1 Activation Supports the Anabolic Malignant State
- (2013) S. Santagata et al. SCIENCE
- Targeting the Apo2L/TRAIL system for the therapy of autoimmune diseases and cancer
- (2012) Luis Martinez-Lostao et al. BIOCHEMICAL PHARMACOLOGY
- Bortezomib and TRAIL: A perfect match for apoptotic elimination of tumour cells?
- (2012) L.H.A.M. de Wilt et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Synergistic TRAIL Sensitizers from Barleria alluaudii and Diospyros maritima
- (2012) Emily L. Whitson et al. JOURNAL OF NATURAL PRODUCTS
- On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics
- (2012) L Y Dimberg et al. ONCOGENE
- Effects of cucurbitacins on cell morphology are associated with sensitization of renal carcinoma cells to TRAIL-induced apoptosis
- (2011) Curtis J. Henrich et al. APOPTOSIS
- Targeting the extrinsic apoptosis signaling pathway for cancer therapy
- (2011) Thomas J. Sayers CANCER IMMUNOLOGY IMMUNOTHERAPY
- Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas
- (2011) Marco Giaisi et al. INTERNATIONAL JOURNAL OF CANCER
- Synthesis of Rocaglamide Hydroxamates and Related Compounds as Eukaryotic Translation Inhibitors: Synthetic and Biological Studies
- (2011) Christina M. Rodrigo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biomimetic Photocycloaddition of 3-Hydroxyflavones: Synthesis and Evaluation of Rocaglate Derivatives as Inhibitors of Eukaryotic Translation
- (2010) Stéphane P. Roche et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?
- (2010) Yohannes Mebratu et al. CELL CYCLE
- Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression
- (2010) M Bleumink et al. CELL DEATH AND DIFFERENTIATION
- Clerodane Diterpenes fromCasearia argutaThat Act As Synergistic TRAIL Sensitizers
- (2010) Emily L. Whitson et al. JOURNAL OF NATURAL PRODUCTS
- A cell-based high-throughput screen to identify synergistic TRAIL sensitizers
- (2008) Nancy Lynn Booth et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- FLIP as an Anti-Cancer Therapeutic Target
- (2008) Jin Kuk Yang YONSEI MEDICAL JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search